A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain
Clinical trial NCT05648669 · UNKNOWN
Trial details
- NCT number
- NCT05648669
- Sponsor
- Qilu Pharmaceutical (Hainan) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-04
- Primary completion
- 2023-07-01
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.